ADMA Biologics, Inc. (ADMA)
15.39
-0.31
(-1.97%)
USD |
NASDAQ |
Mar 06, 16:00
15.40
0.00 (0.00%)
After-Hours: 20:00
ADMA Biologics SG&A Expense (TTM) : 96.42M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Marker Therapeutics, Inc. | 4.365M |
| AtriCure, Inc. | 311.02M |
| Ligand Pharmaceuticals, Inc. | 92.45M |
| ACADIA Pharmaceuticals, Inc. | 548.89M |
| Savara, Inc. | 37.38M |